Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$33.00 USD
+0.08 (0.24%)
Updated May 10, 2024 04:00 PM ET
After-Market: $33.03 +0.03 (0.09%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Earnings News For AGIO
-
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
-
Agios Pharmaceuticals: Q1 Earnings Snapshot
-
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
-
Agios Reports Business Highlights and First Quarter 2024 Financial Results
-
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
-
Agios (AGIO) Q4 Earnings & Revenues Fall Short of Estimates
-
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Misses Revenue Estimates
-
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
-
Earnings Preview: Agios Pharmaceuticals (AGIO) Q4 Earnings Expected to Decline
-
Agios (AGIO) Reports Narrower-Than-Expected Q3 Loss, Lags Sales
-
Agios Pharmaceuticals: Q3 Earnings Snapshot
-
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
-
Agios (AGIO) Q2 Earnings Beat Estimates, Revenues In Line
-
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Tops Revenue Estimates
-
Agios Pharmaceuticals: Q2 Earnings Snapshot
-
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
-
Agios (AGIO) Q1 Earnings Beat Estimates, Revenues Up Y/Y
-
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates
-
Agios Pharmaceuticals: Q1 Earnings Snapshot
-
Agios Reports Business Highlights and First Quarter 2023 Financial Results
-
Agios (AGIO) Q4 Earnings Beat Estimates, Revenues Miss
-
Agios Pharmaceuticals (AGIO) Beats Q4 Earnings Estimates
-
Agios Reports Fourth Quarter and Full Year 2022 Financial Results
-
Agios (AGIO) Q3 Loss Narrower Than Expected, Sales Miss
-
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Lags Revenue Estimates